Focus on antimicrobial use in the era of increasing antimicrobial resistance in ICU.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

12 citing papers in PubMed.

1. An agent-based model on antimicrobial de-escalation in intensive care units: Implications on clinical trial design.PloS one · 2024
   Article
2. Evaluation ofOman medical journal · 2022
   Article
3. Epigenetic-Mediated Antimicrobial Resistance: Host versus Pathogen Epigenetic Alterations.Antibiotics (Basel, Switzerland) · 2022
   Review
4. TheMicroorganisms · 2022
   Article
5. The use of antibiotics in the intensive care unit of a tertiary hospital in Malawi.BMC infectious diseases · 2020
   Article
6. Clinical epigenetics and multidrug-resistant bacterial infections: host remodelling in critical illness.Epigenetics · 2020
   Review
7. [Infections due to multidrug-resistant pathogens : Pathogens, resistance mechanisms and established treatment options].Der Anaesthesist · 2019
   Review
8. A complete and multifaceted overview of antibiotic use and infection diagnosis in the intensive care unit: results from a prospective four-year registration.Critical care (London, England) · 2018
   Article
9. Feasibility of Antimicrobial Stewardship (AMS) in Critical Care Settings: A Multidisciplinary Approach Strategy.Medical sciences (Basel, Switzerland) · 2018
   Article
10. Emerging and re-emerging infectious disease in otorhinolaryngology.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2018
    Review
11. The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship.Intensive care medicine · 2017
    Review
12. Quality indicators in intensive care medicine for Germany - third edition 2017.German medical science : GMS e-journal · 2017
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as